PubRank

M V Johnston

Author PubWeight™ 126.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future. Neurology 2008 2.31
2 Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 1990 2.27
3 Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant. J Pediatr 1992 1.82
4 A randomized efficacy and feasibility study of imagery in acute stroke. Clin Rehabil 2001 1.67
5 Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest. Ann Thorac Surg 1999 1.65
6 Mental practice combined with physical practice for upper-limb motor deficit in subacute stroke. Phys Ther 2001 1.57
7 Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness. Mult Scler 2002 1.54
8 Selective vulnerability in the neonatal brain. Ann Neurol 1998 1.52
9 Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann Thorac Surg 2001 1.50
10 Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 2000 1.49
11 Choline acetyltransferase activity in striatum of neonatal rats increased by nerve growth factor. Science 1985 1.41
12 Diffusion tensor imaging in children with periventricular leukomalacia: variability of injuries to white matter tracts. AJNR Am J Neuroradiol 2007 1.40
13 Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 2004 1.36
14 Self-care self-efficacy, quality of life, and depression after stroke. Arch Phys Med Rehabil 2000 1.31
15 Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res 1986 1.30
16 Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci U S A 1979 1.27
17 Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr 1997 1.24
18 Outcome measures in spinal cord injury: recent assessments and recommendations for future directions. Spinal Cord 2009 1.23
19 Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 1988 1.21
20 Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res 1979 1.21
21 Diffusion tensor imaging of periventricular leukomalacia shows affected sensory cortex white matter pathways. Neurology 2002 1.19
22 Modified constraint induced therapy: a randomized feasibility and efficacy study. J Rehabil Res Dev 2001 1.16
23 Nitric oxide mediates neurologic injury after hypothermic circulatory arrest. Ann Thorac Surg 1999 1.16
24 Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 1999 1.12
25 Predictors of dysphagia after spinal cord injury. Arch Phys Med Rehabil 1999 1.10
26 Hematological monitoring during therapy with carbamazepine in children. Ann Neurol 1983 1.09
27 Neocortical cholinergic innervation: a description of extrinsic and intrinsic components in the rat. Exp Brain Res 1981 1.04
28 Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 1990 1.03
29 Cerebrospinal fluid monoamine metabolites in patients with infantile spasms. Neurology 1984 1.02
30 Development of amino acid receptors in frontal cortex from girls with Rett syndrome. Ann Neurol 1999 1.01
31 Functional outcome of hemorrhagic and nonhemorrhagic stroke patients after in-patient rehabilitation. Am J Phys Med Rehabil 1996 1.01
32 Neonatal lead exposure impairs development of rodent barrel field cortex. Proc Natl Acad Sci U S A 2000 1.01
33 Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1991 0.99
34 Model of Wernicke's encephalopathy. Arch Neurol 1981 0.98
35 Glutamate excitotoxicity: a mechanism of neurologic injury associated with hypothermic circulatory arrest. J Thorac Cardiovasc Surg 1994 0.98
36 Quantitative assessment of neuroprotection against NMDA-induced brain injury. Exp Neurol 1989 0.97
37 Brief post-hypoxic-ischemic hypothermia markedly delays neonatal brain injury. Brain Dev 1997 0.97
38 Neuroimaging studies in Rett syndrome. Brain Dev 2001 0.96
39 Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience 2007 0.96
40 Neurologic injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg 1996 0.96
41 MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur J Pharmacol 1987 0.96
42 Periventricular leukomalacia: relationship between lateral ventricular volume on brain MR images and severity of cognitive and motor impairment. Radiology 2000 0.95
43 Cost-benefits of medical rehabilitation: review and critique. Arch Phys Med Rehabil 1983 0.95
44 Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen. Neuron 1989 0.95
45 Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neuroscience 1990 0.95
46 Neuronal nitric oxide synthase inhibition reduces neuronal apoptosis after hypothermic circulatory arrest. Ann Thorac Surg 1997 0.92
47 Shoulder pain and subluxation after stroke: correlation or coincidence? Am J Occup Ther 1996 0.92
48 Competence in discourse as a measure of social integration and quality of life in persons with traumatic brain injury. Brain Inj 1998 0.92
49 Role of glutamate receptor-mediated excitotoxicity in bilirubin-induced brain injury in the Gunn rat model. Exp Neurol 1998 0.92
50 Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol Aging 1989 0.91
51 Right-sided brain lesions in infants following extracorporeal membrane oxygenation. Pediatrics 1988 0.90
52 10.5-eV photoionization mass spectrometry of aliphatic compounds. J Am Soc Mass Spectrom 1990 0.89
53 Excitatory amino acid neurotoxicity in the developing brain. NIDA Res Monogr 1993 0.89
54 Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain. Stroke 1986 0.89
55 Long-term use of high-dose benzoate and dextromethorphan for the treatment of nonketotic hyperglycinemia. J Pediatr 1998 0.88
56 Methylazoxymethanol treatment of fetal rats results in abnormally dense noradrenergic innervation of neocortex. Science 1979 0.88
57 RNA editing of a human glutamate receptor subunit. Brain Res Mol Brain Res 1994 0.88
58 Expression of NMDA receptor subunit mRNA after MK-801 treatment in neonatal rats. Brain Res Dev Brain Res 1998 0.87
59 Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology 1985 0.87
60 Prevalence and identification of problems in daily functioning in a primary medicine clinic. Disabil Rehabil 2000 0.87
61 Effects of hypoxia-ischemia on monoamine metabolism in the immature brain. Ann Neurol 1984 0.87
62 Ontogeny of neurochemical markers for noradrenergic, GABAergic, and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate. J Neurochem 1980 0.86
63 Ontogeny of non-NMDA glutamate receptors in rat barrel field cortex: I. Metabotropic receptors. J Comp Neurol 1997 0.86
64 Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. Neurology 2001 0.85
65 Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus. Exp Neurol 1990 0.84
66 Assessing the impact of cerebral injury after cardiac surgery: will determining the mechanism reduce this injury? Ann Thorac Surg 1999 0.84
67 Hypoxia-ischemia produces focal disruption of glutamate receptors in developing brain. Brain Res 1987 0.84
68 Pathogenesis of hypoxic-ischemic brain injury in a perinatal rodent model. Neurosci Lett 1984 0.84
69 Prolonged suppression of brain nitric oxide synthase activity by 7-nitroindazole protects against cerebral hypoxic-ischemic injury in neonatal rat. Brain Dev 2001 0.84
70 Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome. Neuroscience 2006 0.84
71 Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience 1990 0.83
72 Susceptibility of brain to AMPA induced excitotoxicity transiently peaks during early postnatal development. Brain Res 1992 0.83
73 Ontogeny of non-NMDA glutamate receptors in rat barrel field cortex: II. Alpha-AMPA and kainate receptors. J Comp Neurol 1997 0.83
74 Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury. Ann Neurol 1983 0.83
75 MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats. Neuroscience 1990 0.83
76 Brain neurotransmitters and neuromodulators in pediatrics. Pediatrics 1982 0.83
77 Evidence for transient perinatal glutamatergic innervation of globus pallidus. J Neurosci 1987 0.83
78 Application of the ART-2a algorithm to laser ablation aerosol mass spectrometry of particle standards. Anal Chem 2001 0.83
79 The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain. Neurosci Lett 1986 0.82
80 AMPA glutamate receptor antagonism reduces neurologic injury after hypothermic circulatory arrest. Ann Thorac Surg 1995 0.82
81 The ontogeny of glutamate receptors in rat barrel field cortex. Brain Res Dev Brain Res 1995 0.82
82 Oligonucleotide sequence and composition determined by matrix-assisted laser desorption/ionization. Anal Chem 1996 0.82
83 Development of central neurotransmitter-specified neuronal systems: implications for pediatric neuro-psychiatric disorders. Acta Neurol Scand 1984 0.81
84 Perinatal hypoxia-ischemia disrupts striatal high-affinity [3H]glutamate uptake into synaptosomes. J Neurochem 1986 0.81
85 Glutamate recognition sites in human fetal brain. Neurosci Lett 1988 0.81
86 Development of central neurotransmitter systems. Ciba Found Symp 1981 0.81
87 Neuroprotective effects of MK-801, TCP, PCP and CPP against N-methyl-D-aspartate induced neurotoxicity in an in vivo perinatal rat model. Brain Res 1989 0.81
88 Hypoxic-ischemic brain injury in the newborn. Cellular mechanisms and potential strategies for neuroprotection. Clin Perinatol 1997 0.81
89 The severity of excitotoxic brain injury is dependent on brain temperature in immature rat. Neurosci Lett 1991 0.80
90 In vitro and in vivo pharmacology of trans- and cis-(+-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects. J Neurochem 1991 0.80
91 Effects of neonatal cholinergic basal forebrain lesions on excitatory amino acid receptors in neocortex. Int J Dev Neurosci 1999 0.80
92 Early rehabilitation for stroke patients: a new look. Arch Phys Med Rehabil 1984 0.79
93 MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets. Brain Res Dev Brain Res 2001 0.79
94 Use of toxins to disrupt neurotransmitter circuitry in the developing brain. Prog Brain Res 1988 0.79
95 The monosialoganglioside, GM1, reduces neurologic injury associated with hypothermic circulatory arrest. Surgery 1993 0.79
96 Distinguishing small molecular mass differences of proteins by mass spectrometry. Anal Biochem 1998 0.79
97 Quinolinate-induced injury is enhanced in developing rat brain. Brain Res Dev Brain Res 1994 0.79
98 Cost-effectiveness of the Medicare three-hour regulation. Arch Phys Med Rehabil 1986 0.78
99 Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy. Pediatr Neurol 2001 0.78
100 Shoulder subluxation after stroke: a comparison of four supports. Arch Phys Med Rehabil 1995 0.78
101 Bond-selective photodissociation of aliphatic disulfides. J Am Soc Mass Spectrom 1995 0.78
102 Induction of neuronal nitric oxide after hypothermic circulatory arrest. Ann Thorac Surg 1996 0.78
103 Adverse behavioral reactions in children treated with carbamazepine (Tegretol). J Pediatr 1982 0.77
104 Outcomes evaluation in TBI Rehabilitation. Part II: measurement tools for a nationwide data system. Arch Phys Med Rehabil 1994 0.77
105 Monosialoganglioside GM1 inhibits neurotoxicity after hypothermic circulatory arrest. Surgery 1998 0.77
106 Experimental neuronal injury in the newborn lamb: a comparison of N-methyl-D-aspartic acid receptor blockade and nitric oxide synthesis inhibition on lesion size and cerebral hyperemia. Pediatr Res 1995 0.77
107 Brain O2 consumption and glutamate release during hypoglycemic coma in piglets are temperature sensitive. Am J Physiol 1999 0.77
108 Delayed increase in neuronal nitric oxide synthase immunoreactivity in thalamus and other brain regions after hypoxic-ischemic injury in neonatal rats. Exp Neurol 2001 0.77
109 A model of methotrexate encephalopathy: neurotransmitter and pathologic abnormalities. J Child Neurol 1986 0.77
110 Mass accuracy and sequence requirements for protein database searching. Anal Biochem 1999 0.77
111 Pathophysiology of cerebral injury and future management. J Card Surg 1997 0.77
112 Laminar distribution of cholinergic markers in neocortex: effects of lesions. J Neurosci Res 1981 0.77
113 Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy. Am J Phys Med Rehabil 2000 0.77
114 Effect of glycine and glycine receptor antagonists on NMDA-induced brain injury. Neurosci Lett 1989 0.77
115 Neurotransmitter chemistry of lissencephalic cortex induced in ferrets by fetal treatment with methylazoxymethanol acetate. Brain Res 1982 0.77
116 Pharmacology of N-methyl-D-aspartate-induced brain injury in an in vivo perinatal rat model. Synapse 1990 0.77
117 Nonketotic hyperglycinemia: pathophysiological role of NMDA-type excitatory amino acid receptors. Ann Neurol 1990 0.77
118 Dexamethasone potentiates NMDA receptor-mediated neuronal injury in the postnatal rat. Eur J Pharmacol 1994 0.77
119 Anodal block in F-wave studies. Arch Phys Med Rehabil 1998 0.77
120 Clinical markers in CSF for determining neurologic deficits after thoracoabdominal aortic aneurysm repairs. Ann Thorac Surg 1997 0.77
121 Coordinated and adequately funded state streams for rehabilitation of newly injured persons with tbi. J Head Trauma Rehabil 2001 0.77
122 Trihexyphenidyl in posthemorrhagic dystonia: motor and language effects. Pediatr Neurol 1999 0.76
123 Synaptic neurochemistry of the basal forebrain cholinergic projection. Psychopharmacol Bull 1983 0.76
124 Effects of fetal treatment with methylazoxymethanol acetate at various gestational dates on the neurochemistry of the adult neocortex of the rat. J Neurochem 1981 0.76
125 Characterizing DNA photo-oxidation reactions by high-resolution mass measurements with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Mass Spectrom 2000 0.76
126 Effects of postnatal hypoxia-ischemia on cholinergic neurons in the developing rat forebrain: choline acetyltransferase immunocytochemistry. Brain Res 1987 0.76
127 Identification of single stranded regions of DNA by enzymatic digestion with matrix-assisted laser desorption/ionization analysis. J Am Soc Mass Spectrom 1999 0.76
128 Apoptosis detection in brain using low-magnification dark-field microscopy. Exp Neurol 1999 0.76
129 The pursuit of effective neuroprotection during infant cardiac surgery. Semin Pediatr Neurol 1999 0.76
130 New insights into mechanisms of neuronal damage in the developing brain. Pediatr Neurosci 1986 0.76
131 Incidence of dislocation following hip arthroplasty for patients in the rehabilitation setting. Am J Phys Med Rehabil 1996 0.76
132 Purine and monoamine metabolites in cerebrospinal fluid. Adv Exp Med Biol 1986 0.76
133 HA-966 (1-hydroxy-3-aminopyrrolidone-2) selectively reduces N-methyl-D-aspartate (NMDA)-mediated brain damage. Neurosci Lett 1989 0.75
134 Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D,L-AP3) and MK-801 against ibotenate induced brain injury. Neurosci Lett 1992 0.75
135 Statistical approach to ordinal measures. Arch Phys Med Rehabil 1989 0.75
136 'What constitutes cerebral palsy?'. Dev Med Child Neurol 1998 0.75
137 A perspective on Wright and Linacre. Arch Phys Med Rehabil 1990 0.75
138 Rapid nonisotopic analysis of glutamate receptor gene expression using reverse transcription-polymerase chain reaction. J Recept Res 1994 0.75
139 Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy. Dev Med Child Neurol 1999 0.75
140 Use of intravenous immune globulin in the treatment of seizure disorders. J Allergy Clin Immunol 1989 0.75
141 Ion decomposition versus molecular size probed by vacuum ultraviolet photoionization. J Am Soc Mass Spectrom 1991 0.75
142 Analysis of stage-sequential change in rehabilitation research. Am J Phys Med Rehabil 1995 0.75
143 Enhancing the detection of sulfate particles for laser ablation aerosol mass spectrometry. Anal Chem 2001 0.75
144 Methylazoxymethanol acetate ablation of mouse cerebellar granule cells: effects on synaptic neurochemistry. Dev Neurosci 1982 0.75
145 Ion mobility spectrometry of gas-phase ions from laser ablation of solids in air at ambient pressure. Appl Spectrosc 2007 0.75
146 The role of the monosialoganglioside, GM1 as a neuroprotectant in an experimental model of cardiopulmonary bypass and hypothermic circulatory arrest. Ann N Y Acad Sci 1998 0.75
147 Risks of neuroleptic drugs in children. J Child Neurol 1987 0.75
148 N-methyl-D-aspartate-mediated injury enhances quisqualic acid-stimulated phosphoinositide turnover in perinatal rats. J Neurochem 1992 0.75
149 Isomer identification by metastable decay rates of laser-produced ions. Anal Chem 1988 0.75
150 Unilateral proptosis due to orbital pseudotumor in a patient with Hashimoto's thyroiditis. Metabolism 1972 0.75
151 Anemia and serum protein deficiencies in patients with traumatic spinal cord injury. J Spinal Cord Med 1997 0.75
152 The selective ionotropic-type quisqualate receptor agonist AMPA is a potent neurotoxin in immature rat brain. Brain Res 1990 0.75
153 Concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid from human infants in the perinatal period. J Neurochem 1984 0.75
154 Photodissociation-photoionization mass spectrometry of n-octene isomers. Anal Chem 1990 0.75
155 Effects of intraventricular methotrexate on cerebrospinal fluid monoamine metabolites in rhesus monkeys. Cancer Treat Rep 1986 0.75
156 Effect of clonidine on platelet alpha 2-adrenoreceptors and plasma norepinephrine of children with Tourette syndrome. Dev Med Child Neurol 1985 0.75
157 Pharmacologic advances in seizure control. Pediatr Clin North Am 1981 0.75
158 Perinatal hypoxic-ischemic brain injury enhances quisqualic acid-stimulated phosphoinositide turnover. J Neurochem 1988 0.75
159 Relationship between primitive reflexes in stroke patients and rehabilitation outcome. Stroke 1978 0.75
160 Unimolecular photochemistry of n-alkenes studied by photodissociation-photoionization mass spectrometry. J Am Soc Mass Spectrom 1993 0.75
161 Cerebrospinal fluid biogenic amine metabolites in children during treatment for acute lymphocytic leukemia. Pediatr Res 1986 0.75
162 Measuring the capacity of families to provide unpaid support for a disabled family member: using BIGSTEPS to identify primary and secondary dimensions. J Outcome Meas 2000 0.75
163 Outcomes evaluation in TBI rehabilitation. Part III: Ethical perspectives and social policy. Arch Phys Med Rehabil 1994 0.75
164 Reliability of disability scales. Arch Phys Med Rehabil 1986 0.75
165 Acute experimental neuronal injury in the newborn lamb: US characterization and demonstration of hemodynamic effects. Pediatr Radiol 1993 0.75
166 Transient hypoxia alters striatal catecholamine metabolism in immature brain: an in vivo microdialysis study. J Neurochem 1990 0.75
167 A reverse transcription-polymerase chain reaction study of p75 nerve growth factor receptor gene expression in developing rat cerebellum. Int J Dev Neurosci 1994 0.75
168 Excitotoxic brain injury suppresses striatal high-affinity glutamate uptake in perinatal rats. J Neurochem 1991 0.75
169 Cerebrospinal fluid cyclic nucleotide alterations in the Lesch-Nyhan syndrome. Adv Exp Med Biol 1989 0.75
170 Muscarinic cholinergic receptors in human infant forebrain: [3H]quinuclidinyl benzilate binding in homogenates and quantitative autoradiography in sections. Brain Res 1985 0.75
171 Developmental neurochemistry: pharmacology and toxicology. Proc West Pharmacol Soc 1985 0.75
172 Effects of hypoxia-ischemia and MK-801 treatment on the binding of a phencyclidine analogue in the developing rat brain. Stroke 1990 0.75
173 Quantitative autoradiographic localization of NMDA, quisqualate and PCP receptors in the frog tectum. Brain Res 1989 0.75
174 Impact of perinatal hypoxia-ischemia on developing neurotransmitter systems. Int J Neurol 1984 0.75
175 Functional hyperinnervation of cerebral cortex by noradrenergic neurons results from fetal lesions: parallels with schizophrenia. Psychopharmacol Bull 1980 0.75
176 Base specificity of oligonucleotide digestion by calf spleen phosphodiesterase with matrix-assisted laser desorption ionization analysis. Anal Biochem 1998 0.75